Hence, it is possible that growth of the bone metastatic PCa organoids is highly dependent on mTOR-mediated glutamine- and/or lipid metabolism, making them particularly susceptible to combined mTORC1/2 inhibition. Here, MTOR is linked to posterior cortical atrophy.